| Advice You |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Ethics > Business Ethics Case Study; Unbelievable Government Credit Card Abuse |
|
Advice You - Business Ethics Case Study; Unbelievable Government Credit Card Abuse
In business management classes across the country MBA students study business ethics. In fact, there are no According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product w MBA degrees available that are called Ethics MBAs. But in the real world how ethical is the business comm ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in nity? How ethical is our own government? How many business travelers for their corporations charge persona lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. l items to their credit cards of their corporations? Corporations watch this very closely to make sure every here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe ne follows the rules. Not everyone follows the rules and often there are people who go to extreme lengths t d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro hide their misdeeds. From a business ethics standpoint corporations and their workers are much more honest ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc and forthright than those who work in government. In fact government credit card abuse at all levels of go easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ernment is at an all-time high. It is so bad that the federal government actually had to make another law to nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically try to curb the abuse of government credit cards. Has this new law helped? Actually it looks as if it has and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ on paper audits but in reality those fine folks in government still abuse their government credit cards, whi ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi h is taxpayers money. The problem is so severe and the punishment so little that nothing is really being do ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a ne. That is to say the problem is running rampant still. Simply instituting controls and checks and balanc dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod s on government credit cards does not alleviate the fraud. Dishonesty in government is the norm and althoug cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin h many people believe that those who work in government are of less IQ they are still clever enough to beat tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen he system and steal taxpayers money. From an MBA standpoint of fiscal management this is a good case study. t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel A piece of corporate credit cards or government credit cards must be followed up on. It is essential to ma ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust ke sure that the purchase is made by government employees are indeed for a facial government business and no y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products personal pleasure; such as gentlemen's clubs, personal car washes or a dinner for a family of four for pers . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de onal use. It appears we cannot trust those fine folks in government and it is about time that we enforced t elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip e letter of the law on to the government and the workers who think they are above it. Consider this in 2006 tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:The Do's and Don'ts of Starting a Business
|